Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
The woman I admire the most professionally… Jane Goodall
“The least I can do is speak out for those who cannot speak for themselves.”
March 14th, 2019
by
IR Dept
Read More
Inspirational women - Kate Hill
To mark International Women’s Day, IR Department Account Director Gabriella Hold sat down with Kate Hill, who is a Non-Executive Director across a number of listed company boards, and Company Secretary for our client, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA.)
March 8th, 2019
by
IR Dept
Read More
- 1
